1
|
Gong H, Zhong H, Cheng L, Li LP, Zhang DK. Post-translational protein lactylation modification in health and diseases: a double-edged sword. J Transl Med 2024; 22:41. [PMID: 38200523 PMCID: PMC10777551 DOI: 10.1186/s12967-023-04842-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Accepted: 12/27/2023] [Indexed: 01/12/2024] Open
Abstract
As more is learned about lactate, it acts as both a product and a substrate and functions as a shuttle system between different cell populations to provide the energy for sustaining tumor growth and proliferation. Recent discoveries of protein lactylation modification mediated by lactate play an increasingly significant role in human health (e.g., neural and osteogenic differentiation and maturation) and diseases (e.g., tumors, fibrosis and inflammation, etc.). These views are critically significant and first described in detail in this review. Hence, here, we focused on a new target, protein lactylation, which may be a "double-edged sword" of human health and diseases. The main purpose of this review was to describe how protein lactylation acts in multiple physiological and pathological processes and their potential mechanisms through an in-depth summary of preclinical in vitro and in vivo studies. Our work aims to provide new ideas for treating different diseases and accelerate translation from bench to bedside.
Collapse
Affiliation(s)
- Hang Gong
- Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu, China
| | - Huang Zhong
- Department of Gastroenterology, Zigong First People's Hospital, Zigong, Sichuan, China
| | - Long Cheng
- Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu, China
| | - Liang-Ping Li
- Department of Gastroenterology, Sichuan Academy of Medical Sciences and Sichuan People's Hospital, Chengdu, Sichuan, China.
| | - De-Kui Zhang
- Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
| |
Collapse
|
2
|
Yogosawa S, Nakayama J, Nishi M, Ryo A, Yoshida K. Carbonic anhydrase 13 suppresses bone metastasis in breast cancer. Cancer Treat Res Commun 2021; 27:100332. [PMID: 33588197 DOI: 10.1016/j.ctarc.2021.100332] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 02/02/2021] [Accepted: 02/05/2021] [Indexed: 02/08/2023]
Abstract
Metastatic progression is the leading cause of mortality in breast cancer. However, molecular mechanisms that govern this process remain unclear. In this study, we found that carbonic anhydrase 13 (CA13) plays a potential role in suppressing bone metastasis. iRFP713-labeled iCSCL-10A (iRFP-iCSCL-10A) breast cancer cells, which exhibit the hallmarks of cancer stem cells, exerted the ability of bone metastasis in hind legs after 5-week injections, whereas no metastasis was observed in control iRFP713-labeled MCF-10A (iRFP-MCF10A) cells. Transcriptome analysis indicated that the expression of several genes, including metabolism-related CA13, was reduced in bone metastatic iRFP-iCSCL-10A cells. In vitro and in vivo analyses demonstrated that overexpression of CA13 in iRFP-iCSCL-10A cells suppressed migration, invasion, and bone metastasis, together with the reduction of VEGF-A and M-CSF expression. Furthermore, we found that breast cancer patients with a low CA13 expression had significantly shorter overall survival and disease-free survival rates compared to those with higher CA13 expression. These findings suggest that CA13 may act as a novel prognostic biomarker and would be a therapeutic candidate for the prevention of bone metastasis in breast cancer.
Collapse
Affiliation(s)
- Satomi Yogosawa
- Department of Biochemistry, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan
| | - Jun Nakayama
- Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan
| | - Mayuko Nishi
- Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan
| | - Akihide Ryo
- Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan
| | - Kiyotsugu Yoshida
- Department of Biochemistry, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan.
| |
Collapse
|
3
|
Vedad J, Domaradzki ME, Mojica ERE, Chang EJ, Profit AA, Desamero RZB. Conformational Differentiation of α-Cyanohydroxycinnamic Acid Isomers: A Raman Spectroscopic Study. JOURNAL OF RAMAN SPECTROSCOPY : JRS 2017; 48:1282-1288. [PMID: 29225410 PMCID: PMC5720387 DOI: 10.1002/jrs.5209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Two α-cyanohydroxycinnamic acid positional isomers, α-cyano-4-hydroxycinnamic acid (CHCA4) and α-cyano-3-hydroxycinnamic acid (CHCA3), were characterized using Raman spectroscopy. We analyzed the implications of the collected Raman spectral shifts, and verified them through other spectroscopic techniques, to arrive at plausible three dimensional structures of CHCA3 and CHCA4. The positions of these groups were mapped by systematically analyzing the orientation and type of interactions functional groups make in each CHCA isomer. We determined whether or not the carboxylic moieties are forming dimeric links and ascertained the existence of ring-ring π-stacking interactions. We also assessed the nature of the hydrogen bonding between -CN and -OH groups. The results were then taken together to model plausible three dimensional structures for each compound. The data revealed a structure for CHCA4 that matches the published x-ray crystallographic structure. We then applied the same spectral analysis to CHCA3 to reveal its plausible three dimensional structure. The structural details revealed may account for the functional properties of the two α-cyanohydroxycinnamic acid positional isomers.
Collapse
Affiliation(s)
- Jayson Vedad
- Department of Chemistry, York College and The Institute for Macromolecular Assemblies, Jamaica, NY, 11451 and Ph.D Programs in Chemistry and Biochemistry, The Graduate Center of the City University of New York, New York, New York, 10016 (United States)
| | - Maciej E. Domaradzki
- Department of Chemistry, York College and The Institute for Macromolecular Assemblies, Jamaica, NY, 11451 and Ph.D Programs in Chemistry and Biochemistry, The Graduate Center of the City University of New York, New York, New York, 10016 (United States)
| | | | - Emmanuel J. Chang
- Department of Chemistry, York College and The Institute for Macromolecular Assemblies, Jamaica, NY, 11451 and Ph.D Programs in Chemistry and Biochemistry, The Graduate Center of the City University of New York, New York, New York, 10016 (United States)
| | - Adam A. Profit
- Department of Chemistry, York College and The Institute for Macromolecular Assemblies, Jamaica, NY, 11451 and Ph.D Programs in Chemistry and Biochemistry, The Graduate Center of the City University of New York, New York, New York, 10016 (United States)
| | - Ruel Z. B. Desamero
- Department of Chemistry, York College and The Institute for Macromolecular Assemblies, Jamaica, NY, 11451 and Ph.D Programs in Chemistry and Biochemistry, The Graduate Center of the City University of New York, New York, New York, 10016 (United States)
| |
Collapse
|
4
|
Zhang L, Feng G, Zhang X, Ding Y, Wang X. microRNA‑630 promotes cell proliferation and inhibits apoptosis in the HCT116 human colorectal cancer cell line. Mol Med Rep 2017; 16:4843-4848. [PMID: 28791386 DOI: 10.3892/mmr.2017.7159] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2016] [Accepted: 04/20/2017] [Indexed: 11/06/2022] Open
Abstract
Dysregulation of microRNAs (miRNAs) in colorectal cancer provides important opportunities for the development of future miRNA‑based therapies. The present study aimed to assess the role of miRNA‑630 (miR‑630) expression in colorectal cancer. HCT116 human colorectal cancer cells were transfected with miR‑630 inhibitor, mimic or control miRNA, and the effects of miR‑630 dysregulation on cell viability, proliferation and apoptosis were analyzed using MTT and bromodeoxyuridine assays, and an annexin V‑fluorescein isothiocyanate cell apoptosis kit, respectively. In addition, the changes in the protein expression of proliferation‑associated and AKT signaling pathway proteins were analyzed by western blot analysis. The results of the present study demonstrated that overexpression of miR‑630 significantly promoted HCT116 cell proliferation however inhibited apoptosis. Furthermore, miR‑630 overexpression reduced the protein expression of p27, BCL2‑associated X apoptosis regulator, procaspase‑3 and active caspase‑3, and increased the levels of phosphorylated‑AKT and BCL2 apoptosis regulator. The suppression of miR‑630 led to the opposite results. In conclusion, the present findings suggested that miR‑630 may function as an oncogenic miRNA in colorectal cancer, and may promote cellular proliferation and inhibit apoptosis, through the regulation of the expression of p27 and the AKT signaling pathway. The present study suggested that the inhibition of miR‑630 may have potential as an alternative therapeutic strategy for the treatment of patients with colorectal cancer.
Collapse
Affiliation(s)
- Lijuan Zhang
- Department of Oncology, Aerospace Center Hospital, Beijing 100049, P.R. China
| | - Gang Feng
- Department of Oncology, Wuhan Puai Hospital, Wuhan 430033, P.R. China
| | - Xinyan Zhang
- Department of Gastroenterology, Aerospace Center Hospital, Beijing 100049, P.R. China
| | - Yawen Ding
- Department of Oncology, Wuhan Puai Hospital, Wuhan 430033, P.R. China
| | - Xiaojuan Wang
- Department of Oncology, Wuhan Puai Hospital, Wuhan 430033, P.R. China
| |
Collapse
|
5
|
Jo YK, Park MH, Choi H, Lee H, Park JM, Sim JJ, Chang C, Jeong KY, Kim HM. Enhancement of the Antitumor Effect of Methotrexate on Colorectal Cancer Cells via Lactate Calcium Salt Targeting Methionine Metabolism. Nutr Cancer 2017; 69:663-673. [PMID: 28353361 DOI: 10.1080/01635581.2017.1299879] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|